Sign in
Groups
Researchers
Funding
Results
Julen
Oyarzabal Santamarina
Researcher to 2018
Helmholtz Institute for Pharmaceutical Research Saarland
Sarrebruck, Alemania
You are in
Collaborations
Helmholtz Institute for Pharmaceutical Research Saarland
Publications in collaboration with researchers from Helmholtz Institute for Pharmaceutical Research Saarland (2)
2024
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de